Fosun-backed Gland Pharma gets Sebi nod for Rp60bn IPO
KT759 - stock.adobe.com
Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has won approval for its IPO from India’s securities regulator, according to a source close to the deal.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: